BACKGROUND Nearly one-third of offi ce visits for cancer are handled by primary care physicians. Yet, few studies examine patient perspectives on these physicians' roles in their cancer follow-up care or their care preferences.
INTRODUCTION
M ore than one-half of individuals with a diagnosis of cancer are expected to survive for more than 5 years. For cancerous breast and prostate tumors, 5-year survival exceeds 90%. 1 Cancer survivors require extended follow-up cancer care after completion of their active cancer treatment. Survivors' follow-up management entails more than routine surveillance for recurrence of cancer. 2, 3 It also requires proactive care, which includes systematic planning for cancer prevention and patient-centered surveillance based on the survivor's personal risk, cancer therapy, genetic predispositions, lifestyle behaviors, and other comorbid health conditions. 2, 4, 5 Increasing numbers of studies document the importance of primary care clinicians (eg, family physicians, internists, physician assistants, nurse practitioners, and, in some cases, gynecologists) in increasing cancer survivors' screening for recurrence 6, 7 and in providing comprehensive extended follow-up care. [8] [9] [10] [11] [12] [13] Approximately 70% of cancer survivors have
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comorbid conditions that require a comprehensive approach to their medical care. 14, 15 Of the 36.6 million annual physician offi ce visits made for cancer care, nearly one-third (32%) are made to primary care physicians. 2 The American Society of Clinical Oncology projects a medical oncologist shortage by 2020 that will necessitate a multifaceted strategy to meet future cancer follow-up care demands. 16 These data suggest that primary care physicians may increasingly provide the main medical home (ie, usual source of care) for survivors who have completed treatment. 2, 17 Few data are available on the types of physicians (primary care vs cancer-medical, radiation, or surgical oncologists-or cancer-related specialists) that traditionally provide care for adult cancer survivors. 3, 18, 19 Additionally, we know little about their practice patterns for providing cancer screening or surveillance testing for cancer recurrence. 3, 18, 19 Several studies suggest that survivors who see both oncologists and primary care physicians are more likely to receive recommended follow-up care than are survivors who see one or the other. 6, 7 Additional literature documents that primary care physicians, as well as specialists, are concerned about providing cancer follow-up care. [20] [21] [22] [23] [24] [25] Although some research suggests that patients are interested in having their primary care physicians be familiar with issues relevant to cancer survivorship, [26] [27] [28] there is little research that examines patients' preferences for extended follow-up care. 21, 26, 27 The current study therefore focused on long-term survivors of localized breast and prostate cancer and explored their preferences regarding the role of the primary care physician in their extended cancer follow-up care. The overarching goal was to identify the preferences of a rapidly growing patient population characterized by the challenges of future health problems related to their previous cancer therapy and for whom many years of follow-up care can be expected.
METHODS

Setting
This exploratory qualitative study recruited cancer survivors in New Jersey who had received their cancer treatment from 1 of 5 community hospitals (AtlantiCare-The Cancer Care Institute, Somerset Medical Center, South Jersey Healthcare, UMDNJ-The University Hospital, and Virtua Fox Chase Cancer Program) or from 2 National Cancer Institute (NCI)-designated comprehensive cancer centers (The Cancer Institute of New Jersey and Fox Chase Cancer Center). These institutions were chosen to represent the diversity of the area's cancer treating facilities (ie, community hospitals, teaching hospitals, and comprehensive cancer centers). This study was approved by the institutional review boards at the University of Medicine & Dentistry of New Jersey and Fox Chase Cancer Center, as well as by the 5 community hospitals.
Sampling Frame
We recruited a purposive sample of ambulatory, earlystage (I or II) breast and prostate cancer survivors for whom the Institute of Medicine (IOM) authors recommend longitudinal survivorship health care (ie, defi ned as health care other than hormonal therapy 2 or more years from completion of cancer therapy). Patients with severe comorbid conditions that required extensive specialist care coordination (eg, congestive heart failure, myocardial infarction, angina) were excluded. To assess the impact of diversity, the study patients were stratifi ed according to (1) the number of years from treatment (2 to 5, 6 to 9, and 10 years or more) and (2) the location of cancer treatment (community hospital vs cancer center). Additionally, we oversampled African Americans and recruited an agerepresentative sample of New Jersey cancer survivors (ie, one-half were older than 65 years).
Data Collection
In-depth, individual interviews were conducted from March through October 2009. Interviews were conducted in English by telephone (95%) or in person (5%) according to participants' preference. Survivors were referred to the study through their cancer treatment facilities. Study investigators worked with staff in the clinical research offi ces of the cancer centers and hospitals, the survivor clinics, and individual clinicians to identify eligible patients. Potential participants were mailed a letter from the principal investigator (S.V.H.) that introduced and explained the study and contained information about their rights under the Health Insurance Portability and Accountability Act of 1996 and two informed consent forms with a return envelope. Follow-up telephone calls were initiated approximately 3 to 5 days after mailings were sent to gauge study interest. Those interested in participating were asked to return one signed copy of the documentation and were scheduled for interviews. Participants received a $35 American Express gift card for completing the interview.
Interviews ranged from 30 to 90 minutes and were conducted by 2 coauthors with extensive qualitative interviewing experience (J.H. and J.L.). A semistructured interview script was developed using the Cognitive-Social Health Information Processing (C-SHIP) model [29] [30] [31] as the conceptual framework (see the Supplemental Appendix at http://annfammed. org/content/10/5/418/suppl/DC1 for in-depth interview questions). C-SHIP comprises 2 key cognitive constructs (cancer-relevant goals and values that are culturally linked, and cancer-relevant thoughts and beliefs about disease management and health outcomes that affect patient expectations), and 1 key self-regulatory component (cancer-relevant self-management competencies and skills for planning, decision making, and generating and maintaining goal-oriented health behaviors), as well as an emotional component (cancerrelevant affects and feelings). Interview questions were developed to elicit information regarding cancer follow-up care for each of these domains.
The interview elicited information about the transitions of survivors from active cancer treatment, focusing on their understanding of who was providing their follow-up care and their satisfaction with the quality of the follow-up care they had received. The interview did not probe explicitly about comorbid conditions, although patients were asked to give self-ratings of health. Interviews were digitally recorded and transcribed verbatim. Interview transcripts and interviewer fi eld notes served as the data source for this analysis.
Coding and Analysis
Our qualitative analysis used an immersion/crystallization approach. 32 This approach consisted of an iterative process that included cycles of reading, summarizing, and rereading the data. [32] [33] [34] Sections of text were reviewed by 2 sociologists and 1 health psychologist (S.V.H., J.H., and J.L.), who separately and independently read through the data and applied codes to segments of the transcripts. The analysis team met weekly to discuss data analysis, interpretation, and coding while interviews were ongoing, thus facilitating our ability to achieve data saturation for key C-SHIP constructs explored in the study. Differences in interpretation of the data were resolved through discussion. For coded text where there was discrepancy between coders, determination of fi nal code assignment was achieved through discussion and group consensus; we therefore achieved 100% agreement in terms of interrater reliability for coded text segments. We used ATLAS.ti 35 software to facilitate our qualitative analyses and SPSS 18 for Windows (SPSS Inc) to complete the descriptive analyses.
RESULTS
Sixty-two patients were invited to participate in the study; 24 breast cancer and 18 prostate cancer survivors completed interviews for a participation rate of 67% (Table 1) . Individuals who chose not to participate were comparable to respondents in terms of race and age, although men were signifi cantly more likely to refuse participation than women (70% vs 30%, P = .05).
The median age of participants was 64.5 years, and 76% were women. Self-reported race and ethnicity were 69% white, 26% black, 2% Asian, and 2% Latino. Blacks were overrepresented in the sample and more likely to come from the community hospitals (χ 2 = 8.948, P = .030). Approximately three-quarters (78%) were married. Ninety percent reported that they were currently under the care of a primary care physician. All participants reported having received cancer follow-up care within the past year from a cancer specialist (ie, medical oncologist, surgical oncologist, radiation oncologist, 76%), cancer-related specialist (urologist, 36%) and/or a primary care physician (family physician, general internist, or gynecologist, 19%). Some participants reported seeking care from multiple physicians.
Most participants (52%) indicated that cancer survivors should see a cancer specialist rather than a primary care physician for extended follow-up cancer care ( Table 2 ). The one-third (38%) who described a potential role for primary care physicians in providing follow-up cancer care were more likely to report having a college education (67%) compared with those who did not (27%, P = .021). There were no differences between participants in terms of age, race, household income, number of years since treatment, treatment location, or self-reported health. Participants who described primary care roles often qualifi ed their support saying, "If he's informed, I don't see why not…if you're comfortable with your primary care" (participant survivor [PS] 7), and "My primary care physician probably could do it. I just felt more comfortable going to an expert" (PS 2). Most described shared care between the oncologist and primary care physician as the only context in which a primary care physician should provide follow-up care. One survivor noted, "I would love to see a survivor plan be part of the treatment plan… then it could actually be part of my primary care physician's folder…and everybody would be on the same page" (PS 14).
When describing their preferences for cancer specialists in managing their follow-up care, participants focused concretely on aspects that they liked or did not like about their follow-up care, while defi ning what they believed was-or was not-part of their follow-up care. Their narratives were most readily coded around the C-SHIP cognitive constructs of values and goals and patient expectations and beliefs about care that acted as barriers and self-regulatory, action-oriented facilitators of primary care engagement. Several themes emerged regarding barriers, including (1) a need for specialized, expert care; (2) an expectation for care continuity; and (3) the belief that primary care physicians are not engaged in cancer care. Themes relating to their beliefs 
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physicians for follow-up care. Participants strongly preferred to remain in the care of the same doctors and treatment teams who oversaw their active treatment. One noted, "I would want to see the person who did the cancer surgery. That would be the person I'd want to see" (PS 8). For many, their primary care physicians were not engaged in that process. A breast cancer survivor commented that working with an "unfamiliar" doctor would add more stress to her life: "I've dealt with people who…haven't read your fi le. They don't know nothing about it and then they just start assuming" (PS 7). Participants also cited their personal relationships with their cancer doctors as important in continuing follow-up care. "[My oncologist] knew my family. She knew everything, always asked me how my kids were doing" (PS 51).
Beliefs About Care: Primary Care Physicians Are Not Engaged in Cancer Care
Participants (43%) perceived primary care physicians as not engaged in cancer care. Several described their physicians as not being attuned to the needs of cancer survivors. In particular, they were concerned that primary care physicians do not consider a patient's status as a cancer survivor in their diagnostic or treatment decisions. Participants were also concerned that primary care physicians do not monitor cancer "on a day-in and day-out basis" (PS 70). Participants described their primary care physicians as "ignoring" cancer-related issues because either they presume the patient is under oncologic care or they defer and refer cancer-related questions back to oncologists. "[My primary care physician] knew for quite a while there that I When enough time has passed n = 9, 21%
During an extended survivorship period "Well, basically, at the point I'm at now, [transitioning to a primary care physician] would probably be fi ne. Because I'm more comfortable with it now and I kind of have a feeling that…this is gonna be 5 years in November and after that period of time, your other doctor is quite familiar with it" (PS 19).
"After I had talked to the surgeon, and they told me like, uh, there was really nothing they could do for me, that the rest was up to myself, you know, I felt like, hey, if they…if I'm in that state, and I have no PSA level that's showable, then I could ask to go to my family doctor and let him just keep a check on the PSA levels" (PS 16). When reintegrated into noncancer population "Once I'm not taking any medications [laughter] I don't think I need to go to see someone specifi cally, so I don't know whether at that point it would even be considered follow-up care…" (PS 1). 
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was seeing 2 other doctors or 1 other doctor at least… so she pretty much ignored all cancer issues" (PS 23). Although most participants did not report seeing their primary care physician for their cancer-related issues, a few mentioned being confl icted about when to call their primary care physician or their cancer or cancerrelated specialist, saying, "I didn't know that…we don't call our oncologist. We have to call our family doctor for our aches and pains, or whatever" (PS 22).
Self-Regulatory Action-Oriented Strategies: Patients' Preferences for Primary Care Physicians' Engagement in Follow-up Care
Ordering Routine Tests for Screening Although many participants preferred specialist care and did not perceive primary care to be appropriate for follow-up care, they paradoxically described contexts in which they believed primary care physicians could and did participate in their follow-up care (Table 4) . Participants (62%) talked about situations in which their primary care physicians did perform cancer monitoring (eg, ordering or monitoring mammograms or prostate-specifi c antigen testing): "[My primary care physician] knows that I had cancer and, at times, we've coordinated these blood tests. So I go, you know, once for a blood test so they can do the PSA [prostate-specifi c antigen test]…. I think it goes to both of them" (PS 9). Survivors commonly acknowledged that their primary care physicians received copies of their test results, asked how their cancer followup was going, or kept a record of screenings. "I do have a family doctor that I see…he always asks [about my cancer] and he's also in the loop as far as getting reports" (PS 3). Many survivors said that their primary care physicians prescribe medications or perform tests related to the effects of their cancer care, such as stress tests, electrocardiograms, and tests for lung capacity and bone density, or they conducted blood work. Participants generally believed that primary care physicians could and should continue to perform these screening and monitoring functions. Yet, it was clear in their discussions that many did not perceive this type of monitoring as part of their follow-up care. For example, one prostate cancer survivor said at the beginning of the interview that his primary care physician did not do anything involving cancer follow-up care but later in the interview volunteered that "we [my primary care physician and I] always do the PSA" (PS 8). Similarly, a breast cancer survivor said, "[I see my] obstetriciangynecologist annually, but I don't really consider it for cancer follow-up care" (PS 14).
Providing Supplemental Care
Although most study participants wanted to see a cancer specialist for their own cancer follow-up, almost one-third (38%) said that primary care clinicians could be involved in follow-up for supplemental health care. "I'm getting breast exams because my general practitioner gives me a breast exam. At the [cancer center], the nurse practitioner gives me a breast exam. So, I'm OK with that" (PS 10). These survivors actively engaged their primary care physicians in their follow-up care so that they would have an additional safeguard. Some staggered appointments so that their primary care clinicians might catch something in between specialist visits or made a point to have test results sent to their primary care physicians. Yet, others said primary care physicians could be useful as a fi rst-stop doctor-a "beginning diagnostician" to refer a patient to the proper specialist: "I think that they can be the beginning diagnostician…. 
When Enough Time Has Passed
Some participants (21%) described a point in the distant future when their primary care physicians could function as their primary follow-up care doctor. For most, this time was defi ned as after the fi rst 5 years of follow-up or after any medications had been completed. For example, one survivor said, "I would guess after a certain period of time, I would think that would be all right. But I would think in the fi rst couple of years, you'd probably want to stay with a specialist" (PS 15). Others commented that survivors could see their primary care physicians for follow-up when reintegrated into the noncancer population. For example, a prostate cancer survivor said, "Actually that would be a sign that things were normal, so to speak, or that this really was in remission. So as soon as that's feasible, that would be very nice" (PS 9).
DISCUSSION
The cancer survivorship literature highlights a need to improve patient-centered communication and care coordination for long-term cancer survivors. 3, [36] [37] [38] Most studies of cancer survivors' follow-up care use quantitative methods and large cohorts to assess survivor attitudes and health behaviors. 21, 24, 26, 27, [38] [39] [40] There are very few studies that focus on understanding the perspectives of survivors of adult cancers or that use interview methods to gain perspective on what informs their expressed preferences. 28, 41 Our study is the fi rst to
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explore, in-depth in a US context, patient preferences regarding the role of primary care physicians in their extended cancer follow-up care for survivors of adult cancers. By using a patient-centered and qualitative approach, this study provides data to better inform our understandings of factors that guide patient preferences and ultimately affect engagement of primary care in extended cancer follow-up care. Thus, it provides a rich addition to the existing survey research that describes barriers and facilitators of primary care physicians' engagement in cancer follow-up care. Participants in this study, similar to participants in survey studies, 21, 26, 27, 39 reported strong preferences to receive initial follow-up from either cancer or cancerrelated specialists. Additionally, they described limited cancer expertise, limited involvement with original cancer care, and lack of care continuity as barriers to primary care engagement in follow-up. These fi ndings from survivors of adult cancers mirror results from earlier studies of adult survivors of pediatric cancers. For example, Oeffi nger et al reported that 87% of adult survivors of pediatric cancer have a primary care physician, yet only 34% reported ever seeing one for a problem they thought was related to their cancer. 42 Importantly, 31% did not feel a primary care physician could handle a problem related to the previously treated cancer. 42 These results also mirror those reported by Mao et al in a survey study, where approximately one-half of a sample of breast cancer patients reported concerns about the primary care physician's ability to deliver care for cancer-specifi c issues. 26 Although previous work suggests that cancer specialists are well positioned to provide monitoring regarding late and long term-effects associated with cancer treatment, [43] [44] [45] [46] it is becoming increasingly clear that cancer survivors decline to see their oncology specialists regularly for survivor care well beyond the end of their initial cancer treatment. 5, 40, 42 Though most patients in the current study continued to see their cancer specialists, their experiences are not the norm, as documented by Pollack et al, 19 who found that only one-third of long-term cancer survivors continue to seek care from physicians whose specialties are related to their original cancer after 5 years of survival.
Findings from our study highlight a need to further explore when patient perceptions of cancer follow-up care converge and diverge from that recommended by the IOM. It also points to a need for interventions focused on decreasing the knowledge divide. Much of the existing research focuses either on limitations of primary care 39, 47 or how the roles primary care physicians in cancer follow-up can be enhanced through additional training or better communication with their oncology colleagues. 26 Data from the current study and the existing literature underscore an additional need for specialists to educate and discharge their patients with a better understanding of what cancer follow-up care is, its lifelong duration, and the potential for varying degrees of monitoring, as well as the role of the primary care physician. Many of our participants were unaware that cancer follow-up care extends beyond surveillance for recurrence. This knowledge gap is important and needs to be addressed. Such preparation will help survivors and their primary care physicians meaningfully engage in their follow-up care. In addition, research suggests that patients are interested in having their primary care physicians be familiar with issues relevant to cancer survivorship, [26] [27] [28] particularly in light of the current study fi ndings that participants, especially those with higher levels of education, see some value in having primary care physicians engaged in their follow-up care.
This study has several limitations. First, our qualitative methods limit our ability to draw broad conclusions from the data. Second, specialty penetration in the northeast may have affected the views of our participants. Other studies of this type are necessary to determine whether the views of our participants are representative of a broader trend in patient attitudes in the United States. Finally, the study recruitment strategies are important to note. To maximize variation in follow-up care-seeking patterns, we chose to recruit patients through their treating oncologists rather than through their current follow-up care clinician. In addition, we focused on a patient population that did not have complex comorbid conditions. Both strategies may have yielded a sample of cancer survivors who have less regular contact with or lack long-term relationships with their primary care physicians.
Despite the limitations, our strategy of recruiting a purposive sample of patients who were treated in academic centers and community hospital settings facilitates a better understanding of the desires and needs of patients after completing cancer treatment. This study is one of the fi rst to include the perspectives of patients treated in either community oncology offi ces or NCI-designated cancer center settings, thus adding breadth to voices that are reported in the existing literature.
Findings from this study support the need for primary care to engage meaningfully in the case management of our growing population of adult cancer survivors. This study highlights the need for future research and interventions to address both patient and patient-perceived physician knowledge gaps related to cancer follow-up care. For example, multilevel intervention approaches that focus on patient outcomes but that also address patient and physician-level knowledge gaps may be warranted. Additionally, models of care and patient-centered, self-management studies may be needed to understand and enhance current care delivery. Such studies will be crucial to enhance the quality of care received by cancer survivors.
